BIOMAT Database Logo BIOMAT Database Logo

Antibodies to HTLV I and III in sera from two Japanese patients, one with possible pre-AIDS. 1984

T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D017977 Deltaretrovirus A genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), and bovine leukemia (ENZOOTIC BOVINE LEUKOSIS). The type species is LEUKEMIA VIRUS, BOVINE. BLV-HTLV Viruses,HTLV Viruses,HTLV-BLV Viruses,Human T-Cell Leukemia Viruses,Human T-Cell Leukemia-Lymphoma Viruses,Leukemia Viruses, Human T-Cell,T-Cell Leukemia Viruses, Human,Human T Cell Leukemia Lymphoma Viruses,Human T Cell Leukemia Viruses,Leukemia Viruses, Human T Cell,T Cell Leukemia Viruses, Human,BLV HTLV Viruses,HTLV BLV Viruses

Related Publications

T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
Natural antibodies in sera from Japanese individuals infected with HTLV-I do not recognize HTLV-III.
September 1985, Blood,
T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
January 1985, The New England journal of medicine,
T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
Antibodies to HTLV-I in sera from patients with connective tissue diseases.
January 1989, Annals of the rheumatic diseases,
T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.
January 1985, Nature,
T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.
January 1994, West African journal of medicine,
T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
LAV/HTLV-III and HTLV-I antibodies in hemodialysis patients.
January 1986, Nephron,
T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
LAV/HTLV-III neutralizing antibodies in the sera of patients with AIDS, lymphadenopathy syndrome and asymptomatic seropositive individuals.
June 1986, Tumori,
T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
HTLV-III in cells cultured from semen of two patients with AIDS.
October 1984, Science (New York, N.Y.),
T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
May 1984, Science (New York, N.Y.),
T Aoki, and H Miyakoshi, and Y Usuda, and J C Chermann, and F Barré-Sinoussi, and R C Ting, and R C Gallo
Prevalence of antibodies to HTLV-III in quality-assurance sera.
May 1986, Clinical chemistry,
Copied contents to your clipboard!